Pharmacological Intervention to Modulate HDL: What Do We Target?

MLA

Nicholas J. Woudberg, et al. “Pharmacological Intervention to Modulate HDL: What Do We Target?” Frontiers in Pharmacology, vol. 8, Jan. 2018. EBSCOhost, https://doi.org/10.3389/fphar.2017.00989.

APA

Nicholas J. Woudberg, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard W. James, & Miguel A. Frias. (2018). Pharmacological Intervention to Modulate HDL: What Do We Target? Frontiers in Pharmacology, 8. https://doi.org/10.3389/fphar.2017.00989

Chicago

Nicholas J. Woudberg, Sarah Pedretti, Sandrine Lecour, Rainer Schulz, Nicolas Vuilleumier, Richard W. James, and Miguel A. Frias. 2018. “Pharmacological Intervention to Modulate HDL: What Do We Target?” Frontiers in Pharmacology 8 (January). doi:10.3389/fphar.2017.00989.